Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 26 Pain, Postoperative 17 Neoplasms 13 Lung Neoplasms 12 Brain Neoplasms 12 Depression 7 Carcinoma, Hepatocellular 7 Pain 6 Colonic Neoplasms 6 Thyroid Neoplasms 5 Stomach Neoplasms 5 Prostatic Neoplasms 5 Leiomyoma 5 Head and Neck Neoplasms 5 Agnosia 5 Ovarian Neoplasms 4 Multiple Myeloma 4 Delirium 4 Colorectal Neoplasms 4 Anxiety Disorders 4 Supratentorial Neoplasms 3 Rectal Neoplasms 3 Pancreatic Neoplasms 3 Myofibroma 3 Lymphoma 3 Hemorrhage 3 Fatigue 3 Emergence Delirium 3 Chronic Pain 3 Carcinoma, Non-Small-Cell Lung 3

Interventions

Bevacizumab 7 Talc 4 Pleurodesis 4 Thoracoscopy 3 Povidone-Iodine 3 Paclitaxel 3 Drug Therapy 3 Doxycycline 3 Docetaxel 3 Cisplatin 3 Chest Tubes 3 Carboplatin 3 aldesleukin 2 Thoracentesis 2 Taxes 2 Surveys and Questionnaires 2 Sodium Chloride 2 Silver Nitrate 2 Pharmaceutical Preparations 2 Nivolumab 2 Magnetic Resonance Spectroscopy 2 Interleukin-2 2 High-Energy Shock Waves 2 Gemcitabine 2 Fentanyl 2 tocilizumab 1 talimogene laherparepvec 1 romidepsin 1 lipoplatin 1 cediranib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Pleural Effusion, Malignant × Saline Solution × Clear all

NCT01411202 2020-09-25

OPUS

Ottawa Hospital Research Institute

Phase 2 Unknown

Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡